<!DOCTYPE html>
<html>
<head>
<meta charset = "utf-8">
<title>183 卵巢及其他子宮附屬器官之惡性腫瘤</title>
<style type = "text/css">
table{width: 1100px; border-collapse: collapse; background-color: lightblue; font-family: sans-serif; margin:0px auto;}
table, td, th { border: 1px solid black; padding: 4px; }
th { text-align: left; color: white; background-color: darkblue; }
tr.oddrow { background-color: white; }
</style>
</head>
<body>
<table>
<caption>183-卵巢及其他子宮附屬器官之惡性腫瘤</caption>
<thead><tr><th>ICD 183</th>
<th>Gene/Locus name</th>
<th>Location</th>
<th>Gene/Locus</th>
<th>Gene/Locus MIM number</th>
<th>Phenotype MIM number</th>
<th>Match in DOID</th>
<th>Match in Orphanet</th>
<th>Match distinct gene</th>
</tr>
</thead>
<tbody>
<tr class='oddrow'><td>183</td><td>Ovarian cancer, susceptibility to, 1</td><td>3p25-p22</td><td>OVCAS1</td><td><a href="https://www.omim.org/entry/607893?search=607893" target="_blank">607893</a></td><td><a href="https://www.omim.org/entry/607893?search=607893" target="_blank">607893</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>183</td><td>Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide</td><td>3q26.32</td><td>PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO</td><td><a href="https://www.omim.org/entry/171834?search=171834" target="_blank">171834</a></td><td><a href="https://www.omim.org/entry/167000?search=167000" target="_blank">167000</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>183</td><td>Parkin</td><td>6q26</td><td>PRKN, PARK2, PDJ, LPRS2</td><td><a href="https://www.omim.org/entry/602544?search=602544" target="_blank">602544</a></td><td><a href="https://www.omim.org/entry/167000?search=167000" target="_blank">167000</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>183</td><td>Cadherin-1 (E-cadherin; uvomorulin)</td><td>16q22.1</td><td>CDH1, UVO, LCAM, ECAD, BCDS1</td><td><a href="https://www.omim.org/entry/192090?search=192090" target="_blank">192090</a></td><td><a href="https://www.omim.org/entry/167000?search=167000" target="_blank">167000</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>183</td><td>Opioid-binding protein/cell adhesion molecule-like</td><td>11q25</td><td>OPCML</td><td><a href="https://www.omim.org/entry/600632?search=600632" target="_blank">600632</a></td><td><a href="https://www.omim.org/entry/167000?search=167000" target="_blank">167000</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>183</td><td>Catenin (cadherin-associated protein), beta 1, 88kD</td><td>3p22.1</td><td>CTNNB1, MRD19, EVR7</td><td><a href="https://www.omim.org/entry/116806?search=116806" target="_blank">116806</a></td><td><a href="https://www.omim.org/entry/167000?search=167000" target="_blank">167000</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>183</td><td>Murine thymoma viral (v-akt) oncogene homolog-1</td><td>14q32.33</td><td>AKT1, CWS6</td><td><a href="https://www.omim.org/entry/164730?search=164730" target="_blank">164730</a></td><td><a href="https://www.omim.org/entry/167000?search=167000" target="_blank">167000</a></td><td>YES</td><td></td><td></td></tr>
</tbody></table>
</body>
</html>
